Andrew Lin

661 total citations
37 papers, 410 citations indexed

About

Andrew Lin is a scholar working on Hematology, Oncology and Infectious Diseases. According to data from OpenAlex, Andrew Lin has authored 37 papers receiving a total of 410 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Hematology, 12 papers in Oncology and 9 papers in Infectious Diseases. Recurrent topics in Andrew Lin's work include Hematopoietic Stem Cell Transplantation (10 papers), Multiple Myeloma Research and Treatments (7 papers) and Cytomegalovirus and herpesvirus research (7 papers). Andrew Lin is often cited by papers focused on Hematopoietic Stem Cell Transplantation (10 papers), Multiple Myeloma Research and Treatments (7 papers) and Cytomegalovirus and herpesvirus research (7 papers). Andrew Lin collaborates with scholars based in United States, Australia and Netherlands. Andrew Lin's co-authors include Susan Evans, H. James Norton, John W. Devlin, Sergio Giralt, Miguel‐Angel Perales, Susan K. Seo, Julie A. Kase, Lam Thanh Nguyen, Carmen Lau and Carol R. Lauzon and has published in prestigious journals such as SHILAP Revista de lepidopterología, Blood and International Journal of Molecular Sciences.

In The Last Decade

Andrew Lin

30 papers receiving 399 citations

Peers

Countries citing papers authored by Andrew Lin

Since Specialization

Citations

This map shows the geographic impact of Andrew Lin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Andrew Lin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Andrew Lin more than expected).

Fields of papers citing papers by Andrew Lin

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Andrew Lin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Andrew Lin. The network helps show where Andrew Lin may publish in the future.

Co-authorship network of co-authors of Andrew Lin

This figure shows the co-authorship network connecting the top 25 collaborators of Andrew Lin. A scholar is included among the top collaborators of Andrew Lin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Andrew Lin. Andrew Lin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	American Society for Transplantation and Cellular Therapy Series #11: Updated Cytomegalovirus Guidelines in Hematopoietic Cell Transplant and Cellular Therapy Recipients 2025 ·Transplantation and Cellular Therapy ·Fareed Khawaja, Danniel Zamora, Michelle K. Yong, Morgan Hakki, (unknown), Lara Danziger‐Isakov, Andrew Lin, Paul A. Carpenter, Michael Boeckh, Genovefa A. Papanicolaou, Sanjeet Dadwal, Roy F. Chemaly	0
2	The Next Frontier in Tuberculosis Investigation: Automated Whole Genome Sequencing for Mycobacterium tuberculosis Analysis 2024 ·International Journal of Molecular Sciences ·Justin H. J. Ng, (unknown), Andrew Gorzalski, Adam Allred, (unknown), (unknown), Andrew Lin, Shadi Shokralla, Mark Pandori, Godfred Masinde, Ramin Khaksar	4
3	Isatuximab for Delayed Red Cell Engraftment after Allogeneic Hematopoietic Cell Transplantation 2024 ·SHILAP Revista de lepidopterología ·(unknown), (unknown), Andrew Lin, Alexander Chan, (unknown), Sergio Giralt, Miguel‐Angel Perales, Boglarka Gyurkocza	0
4	Reduced-Intensity Compared to Nonmyeloablative Conditioning in Patients with Non-Hodgkin Lymphoma Undergoing Allogeneic Hematopoietic Stem Cell Transplantation 2023 ·Transplantation and Cellular Therapy ·Karthik Nath, (unknown), Samantha Brown, Sean M. Devlin, (unknown), Juliet N. Barker, Sergio Giralt, Boglarka Gyurkocza, Ann A. Jakubowski, Esperanza B. Papadopoulos, Doris M. Ponce, Michael Scordo, Gunjan L. Shah, Miguel‐Angel Perales, Craig S. Sauter, Andrew Lin, Parastoo B. Dahi	0
5	Patterns of CMV infection after letermovir withdrawal in recipients of posttransplant cyclophosphamide–based transplant 2023 ·Blood Advances ·Andrew Lin, Samantha Brown, (unknown), Yeon Joo Lee, Susan K. Seo, Doris M. Ponce, Zainab Shahid, Sergio Giralt, Genovefa A. Papanicolaou, Miguel‐Angel Perales, Brian C. Shaffer	6
6	Impact of omitting post-transplant minidose-methotrexate doses in allogeneic hematopoietic cell transplantation 2022 ·Leukemia & lymphoma ·Andrew Lin, Samantha Brown, Molly Maloy, Josel D. Ruiz, Sean M. Devlin, (unknown), (unknown), Ann A. Jakubowski, Esperanza B. Papadopoulos, Craig S. Sauter, Roni Tamari, Hugo Castro‐Malaspina, Brian C. Shaffer, Juliet N. Barker, Miguel‐Angel Perales, Sergio Giralt, Boglarka Gyurkocza	2
7	Extended-duration letermovir prophylaxis for cytomegalovirus infection after cord blood transplantation in adults 2022 ·Blood Advances ·Ioannis Politikos, Carmen Lau, Sean M. Devlin, (unknown), Andrew Lin, Miguel‐Angel Perales, Gunjan L. Shah, Susan K. Seo, Genovefa A. Papanicolaou, Juliet N. Barker	16
8	Evaluation of Melphalan Exposure in Lymphoma Patients Undergoing BEAM and Autologous Hematopoietic Cell Transplantation 2022 ·Transplantation and Cellular Therapy ·Parastoo B. Dahi, Andrew Lin, Michael Scordo, Jessica Flynn, Sean M. Devlin, Josel D. Ruiz, (unknown), Dean Carlow, Christina Cho, Oscar Lahoud, Miguel‐Angel Perales, Craig S. Sauter, (unknown), Rick Admiraal, Sergio Giralt, Gunjan L. Shah	1
9	Letermovir for Prevention of Cytomegalovirus Reactivation in Haploidentical and Mismatched Adult Donor Allogeneic Hematopoietic Cell Transplantation with Post-Transplantation Cyclophosphamide for Graft-versus-Host Disease Prophylaxis 2020 ·Transplantation and Cellular Therapy ·Andrew Lin, Jessica Flynn, (unknown), (unknown), (unknown), Carmen Lau, (unknown), Sean M. Devlin, Christina Cho, Roni Tamari, Ann A. Jakubowski, Esperanza B. Papadopoulos, Sergio Giralt, Miguel‐Angel Perales, Susan K. Seo, Brian C. Shaffer	32
10	Membranous nephropathy in patients with HIV: a report of 11 cases 2020 ·BMC Nephrology ·Vivek Charu, Nicole K. Andeen, Vighnesh Walavalkar, (unknown), (unknown), Andrew Lin, Richard Sibley, Julian P. T. Higgins, Megan L. Troxell, Neeraja Kambham	12
11	Letermovir for primary and secondary cytomegalovirus prevention in allogeneic hematopoietic cell transplant recipients: Real‐world experience 2019 ·Transplant Infectious Disease ·Andrew Lin, Molly Maloy, Yiqi Su, Valkal Bhatt, (unknown), (unknown), Carmen Lau, (unknown), Juliet N. Barker, Brian C. Shaffer, Sergio Giralt, Ann A. Jakubowski, Esperanza B. Papadopoulos, Genovefa A. Papanicolaou, Susan K. Seo, Miguel‐Angel Perales	65
12	High-dose radiation therapy is needed for intracranial control and long-term survival in patients with non-seminomatous germ cell tumor brain metastases 2019 ·Journal of Neuro-Oncology ·Dana L. Casey, Kenneth L. Pitter, Brandon S. Imber, Andrew Lin, Timothy A. Chan, Kathryn Beal, Yoshiya Yamada, Darren R. Feldman, Jonathan T. Yang	5
13	Measurement of the DNA alkylating agents busulfan and melphalan in human plasma by mass spectrometry 2019 ·Journal of Chromatography B ·Ryan Schofield, Heather Landau, Sergio Giralt, Gunjan L. Shah, Michael Scordo, Andrew Lin, Elaine Zanutto, Lakshmi V. Ramanathan, Melissa S. Pessin, Dean Carlow	9
14	Feasibility, Tolerability, and Patient-Reported Outcomes with Pharmacokinetic (PK)-Directed Dosing of Evomela® (propylene glycol free melphalan) for Multiple Myeloma and AL Amyloidosis Patients Undergoing Autologous Hematopoietic Stem Cell Transplant (AHCT) 2017 ·Blood ·Gunjan L. Shah, Andrew Lin, Ryan Schofield, (unknown), (unknown), Sean M. Devlin, Valkal Bhatt, Stephen Harnicar, Elizabeth Hoover, David J. Chung, Parastoo B. Dahi, Guenther Koehne, Roni Tamari, Dean Carlow, Sergio Giralt, Heather Landau	2
15	Pharmacokinetics and Toxicities after Evomela® (propylene glycol free melphalan) with Autologous Hematopoietic Stem Cell Transplant (AHCT) for Multiple Myeloma and AL Amyloidosis 2017 ·Blood ·Gunjan L. Shah, Heather Landau, (unknown), Ryan Schofield, Andrew Lin, Valkal Bhatt, Stephen Harnicar, Sean M. Devlin, David J. Chung, Parastoo B. Dahi, Guenther Koehne, Roni Tamari, Dean Carlow, Sergio Giralt	2
16	Effects of Obesity on the Efficacy and Toxicity of Induction Chemotherapy in Adult Acute Lymphoblastic Leukemia (ALL) 2015 ·Blood ·Tim Peterson, Andrew Lin, Patrick Hilden, Sean M. Devlin, Nelly G. Adel, Jae H. Park	0
17	Multiplexed Microsphere Suspension Array-Based Immunoassays 2015 ·Methods in molecular biology ·Andrew Lin, Alejandra Salvador, (unknown)	17
18	Influence of obesity on efficacy and toxicity of induction chemotherapy in patients with newly diagnosed acute myeloid leukemia 2012 ·Leukemia & lymphoma ·Andrew Lin, Megan Othus, (unknown), (unknown), Elihu H. Estey	27
19	Isolation of Shiga Toxin–Producing Escherichia coli from Fresh Produce Using STEC Heart Infusion Washed Blood Agar with Mitomycin-C 2012 ·Journal of Food Protection ·Andrew Lin, Lam Thanh Nguyen, (unknown), Julie A. Kase, Insook Son, Carol R. Lauzon	11
20	Lung perfusion in bronchiolo-alveolar carcinoma. A case report. 1969 ·PubMed ·Harvey Wolinsky, Andrew Lin, M. Henry Williams	5

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact